Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Coya Therapeutics (COYA) Revenue (2023 - 2025)

Historic Revenue for Coya Therapeutics (COYA) over the last 3 years, with Q3 2025 value amounting to $3.6 million.

  • Coya Therapeutics' Revenue changed N/A to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 5826.28%. This contributed to the annual value of $3.6 million for FY2024, which is 4078.74% down from last year.
  • Coya Therapeutics' Revenue amounted to $3.6 million in Q3 2025.
  • Coya Therapeutics' 5-year Revenue high stood at $6.0 million for Q4 2023, and its period low was $1952.0 during Q4 2024.
  • For the 3-year period, Coya Therapeutics' Revenue averaged around $1.9 million, with its median value being $257884.0 (2025).
  • Its Revenue has fluctuated over the past 5 years, first plummeted by 9996.75% in 2024, then surged by 10331.76% in 2025.
  • Over the past 3 years, Coya Therapeutics' Revenue (Quarter) stood at $6.0 million in 2023, then crashed by 99.97% to $1952.0 in 2024, then skyrocketed by 182494.98% to $3.6 million in 2025.
  • Its last three reported values are $3.6 million in Q3 2025, $163616.0 for Q2 2025, and $257884.0 during Q1 2025.